Corgenix to Host Conference Call to Discuss First Quarter Results

DENVER, Nov. 6 Corgenix Medical Corporation(OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostictest kits, will host a conference call on Thursday, November 13, 2008, at4:00 PM EST to discuss the Company's financial and operating performance forits first fiscal quarter ended September 30, 2008, and the status of theCompany's product development and marketing activities.

Corgenix invites all those interested in hearing management's discussionof the annual results to join the call by dialing:

A question-and-answer session will follow the presentation by Corgenixmanagement.

A replay will be available for 30 days following the call by dialing(800) 723-0544 for U.S. participants and +1 402 220 2656 for internationalparticipants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specializeddiagnostic kits for immunology disorders, vascular diseases and bone and jointdisorders, including the world's only non-blood-based test for aspirin effect.Corgenix diagnostic products are commercialized for use in clinicallaboratories throughout the world. The company currently sells over 52diagnostic products through a global distribution network. More information isavailable at http://www.corgenix.com.U.S. attendees: (800) 895-0198 International attendees: +1 785 424 1053 Conference code is: CORGENIX

SOURCE Corgenix Medical Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...